Crossmark

A live cell assay of GPCR coupling allows identification of optogenetic tools for controlling Go and Gi signaling

Crossref DOI link: https://doi.org/10.1186/s12915-017-0475-2

Published Online: 2018-01-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ballister, Edward R.

Rodgers, Jessica

Martial, Franck

Lucas, Robert J.
Funding

Funding for this research was provided by:

Human Frontier Science Program (RGP0034/2014)

Biotechnology and Biological Sciences Research Council (BB/K002252/1)
More Information

Article History

Received: 14 November 2017

Accepted: 18 December 2017

First Online: 16 January 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: RJL is a named inventor on a patent application for the use of rod opsin as a therapeutic in retinal degeneration that is currently licensed for clinical development by Acucela Inc. and he has previously provided consultancy services to them on this topic.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.